Lazard Capital Downgrades Palomar Medical (PMTI) to Hold
More News related to PMTI
- Matrix USA Rating Changes 8/27
- Texas Court Issues Markman Ruling in Candela's Suit Against Palomar
- Palomar Medical (PMTI) Reports Q2 Adj-EPS of $0.10, Beats by 1c
- Palomar Medical Reports Financial Results for Second Quarter 2008
- Palomar Medical Technologies to Host Second Quarter 2008 Financial Results Conference Call and Webcast on July 31, 2008
Lazard Capital downgrades Palomar Medical (Nasdaq: PMTI) from Buy to Hold.
Palomar Medical Technologies, Inc. and its subsidiaries engage in the research, development, manufacture, distribution, and sale of laser and light-based products and related disposable items and accessories for medical and cosmetic treatments.
Related Categories
DowngradesStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
